Praziquantel, a new anthelmintic drug with antischistosomal and anticestodal properties, was tested in comparison with a placebo control and a 'positive control' with cyclophosphamide in mammalian test systems in vivo for potential mutagenic effects. The test systems used and the tested doses of Pra
โฆ LIBER โฆ
Mutagenicity studies with praziquantel, a new anthelmintic drug: Tissue-, host-, and urine-mediated mutagenicity assays
โ Scribed by J. Obermeier; H. Frohberg
- Book ID
- 104708661
- Publisher
- Springer-Verlag
- Year
- 1977
- Tongue
- English
- Weight
- 681 KB
- Volume
- 38
- Category
- Article
- ISSN
- 0340-5761
No coin nor oath required. For personal study only.
โฆ Synopsis
Praziquantel, a new anthelmintic drug with activity against all species of schistosomes pathogenic to man, and against a wide range of Cestodes, was tested for mutagenic potential. For the detection of both base substitutions and frameshift mutations, Salmonella typhimurium TA 100 and TA 98 were used as tester strains. Using the plate assay with and without added S-9, host-mediated assay and urine-mediated assay without and after incubation with beta-glucuronidase/arylsulfatase, no mutagenic activity could be detected.
๐ SIMILAR VOLUMES
Mutagenicity studies with Praziquantel,
โ
L. Machemer; D. Lorke
๐
Article
๐
1978
๐
Springer-Verlag
๐
English
โ 650 KB